H.C. Thomas

1.2k total citations
29 papers, 843 citations indexed

About

H.C. Thomas is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, H.C. Thomas has authored 29 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Hepatology and 5 papers in Oncology. Recurrent topics in H.C. Thomas's work include Hepatitis B Virus Studies (15 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (6 papers). H.C. Thomas is often cited by papers focused on Hepatitis B Virus Studies (15 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (6 papers). H.C. Thomas collaborates with scholars based in United Kingdom, Netherlands and Italy. H.C. Thomas's co-authors include Michael Murphy, A. H. Waters, Tim Lister, Paul Metcalfe, John Ord, R. F. SCHINAZI, J P Sommadossi, Arie J. Zuckerman, D K Mason and J. Monjardino and has published in prestigious journals such as The Lancet, Gastroenterology and Gut.

In The Last Decade

H.C. Thomas

29 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.C. Thomas United Kingdom 15 371 300 150 148 111 29 843
Lewellys F. Barker United States 21 1.4k 3.7× 1000 3.3× 89 0.6× 222 1.5× 315 2.8× 64 1.7k
Anders Sönnerborg Sweden 20 718 1.9× 563 1.9× 59 0.4× 259 1.8× 494 4.5× 36 1.5k
S. P. Parker United Kingdom 14 325 0.9× 155 0.5× 62 0.4× 135 0.9× 275 2.5× 18 774
Alfred J. Grindon United States 14 207 0.6× 61 0.2× 215 1.4× 75 0.5× 246 2.2× 41 829
C. K. Lin Hong Kong 15 447 1.2× 228 0.8× 100 0.7× 71 0.5× 193 1.7× 24 814
HarveyJ. Alter United States 7 614 1.7× 538 1.8× 69 0.5× 67 0.5× 228 2.1× 8 897
Germán F. Leparc United States 17 228 0.6× 89 0.3× 149 1.0× 31 0.2× 96 0.9× 43 709
R. Mitchell United Kingdom 12 798 2.2× 26 0.1× 246 1.6× 157 1.1× 413 3.7× 40 1.2k
Jean‐Pierre Allain United Kingdom 14 456 1.2× 260 0.9× 51 0.3× 55 0.4× 541 4.9× 16 1.1k
Juraj Petrík United Kingdom 23 769 2.1× 920 3.1× 99 0.7× 66 0.4× 328 3.0× 59 1.6k

Countries citing papers authored by H.C. Thomas

Since Specialization
Citations

This map shows the geographic impact of H.C. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.C. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.C. Thomas more than expected).

Fields of papers citing papers by H.C. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.C. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.C. Thomas. The network helps show where H.C. Thomas may publish in the future.

Co-authorship network of co-authors of H.C. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of H.C. Thomas. A scholar is included among the top collaborators of H.C. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.C. Thomas. H.C. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leech, Robert, Vijay P.B. Grover, Julie Fitzpatrick, et al.. (2011). 174 FUNCTIONAL CORE MODULATION FOLLOWING TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY WITH L-ORNITHINE L-ASPARTATE: A POTENTIAL NOVEL MECHANISM OF ACTION. Journal of Hepatology. 54. S74–S75. 1 indexed citations
2.
Godkin, Andrew, Peter Openshaw, & H.C. Thomas. (2005). Immune tolerance to hepatitis C virus acquired during engraftment of bone marrow transplant. Journal of Viral Hepatitis. 12(6). 604–608. 3 indexed citations
3.
SCHINAZI, R. F., J P Sommadossi, & H.C. Thomas. (1998). Therapies for viral hepatitis.. 63 indexed citations
4.
Karayiannis, Peter, Sara M. O’Rourke, Michael J. McGarvey, et al.. (1991). A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity. Journal of General Virology. 72(9). 2167–2172. 13 indexed citations
5.
McIntyre, G., et al.. (1991). Pre-core HBV mutants: Response to interferon therapy. Journal of Hepatology. 13. S16–S16. 4 indexed citations
6.
Saldanha, J., et al.. (1990). Cloning and expression of an immunodominant region of the hepatitis delta antigen. Journal of General Virology. 71(2). 471–475. 15 indexed citations
8.
Thomas, H.C., Linda Scully, & J.A. McDonald. (1986). Lymphoblastoid and recombinant α-A Interferon therapy of chronic hepatitis B virus infection. Journal of Hepatology. 3. S193–S197. 16 indexed citations
9.
Murphy, Michael, Paul Metcalfe, H.C. Thomas, et al.. (1986). Use of leucocyte‐poor blood components and HLA‐matched‐platelet donors to prevent HLA alloimmunization. British Journal of Haematology. 62(3). 529–534. 183 indexed citations
10.
Thomas, H.C., Peter Karayiannis, Martin Fowler, & J. Monjardino. (1985). Clinical uses of HBV-DNA assays. Journal of Virological Methods. 10(4). 291–294. 10 indexed citations
11.
Weller, I V, Anna S. Lok, Adrian Mindel, et al.. (1985). Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.. Gut. 26(7). 745–751. 50 indexed citations
12.
Goodall, Alison H., et al.. (1984). Hepatitis B virus and host cell membrane antigens on a primary hepatocellular carcinoma cell line. Liver International. 4(1). 1–6. 4 indexed citations
13.
Weller, Ian, et al.. (1982). Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.. Gut. 23(8). 650–655. 54 indexed citations
14.
Thomas, H.C.. (1980). Introduction. Springer Seminars in Immunopathology. 3(3). 281–283. 3 indexed citations
15.
Thomas, H.C., et al.. (1980). Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice. Gastroenterology. 79(3). 528–532. 26 indexed citations
16.
Thomas, H.C., et al.. (1980). Immunological and Anti-viral Therapy of Chronic Hepatitis B Virus Infection. Clinics in Gastroenterology. 9(1). 85–95. 6 indexed citations
17.
Chadwick, R. G., M.F. Bassendine, E.M. Crawford, H.C. Thomas, & Sheila Sherlock. (1978). HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.. BMJ. 2(6136). 531–533. 44 indexed citations
18.
Jain, Stephan, H.C. Thomas, J. S. Oxford, & Sheila Sherlock. (1978). Trial of ribavirin for the treatment of HBsAg positive chronic liver disease. Journal of Antimicrobial Chemotherapy. 4(4). 367–373. 20 indexed citations
19.
Thomas, H.C., C. J. Ryan, I S Benjamin, Leslie H. Blumgart, & R N MacSween. (1976). The Immune Response in Cirrhotic Rats. Gastroenterology. 71(1). 114–117. 39 indexed citations
20.
Thomas, H.C., et al.. (1974). The induction of tolerance to a soluble protein antigen by oral administration.. PubMed. 27(4). 631–9. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026